Products - Mumps virus


Order no.Antibody specificity/ reagent/ analyteIg classSubstrateSpeciesFormat
EI 2630-9601 G
Mumps virus
IgG

2/20/200 RU/ml
2/20/200 RU/ml
96 x 01
EI 2630-9601 M
Mumps virus
incl. IgG/RF absorbent
IgM

semi-quantitative
semi-quantitative
96 x 01
EI 2630-9601-3 G
Mumps virus AT: strains "Enders"
and "Jeryl Lynn"
IgG

2/20/200 RU/ml
2/20/200 RU/ml
96 x 01
EI 2630-9601-5 M
Mumps virus G5: native antigens,
genotype "G5"
incl. IgG/RF absorbent
IgM

semi-quantitative
semi-quantitative
96 x 01
EI 2630-9601-L G
Mumps virus
antibody determination in CSF
IgG

5/25/50/100 U
5/25/50/100 U
96 x 01
FI 2630-1005 G
FI 2630-1010 G
FI 2630-1005 M
FI 2630-1010 M
FK 2630-1005
FK 2630-1010
Mumps virus
IgG

IgM



infected cells
EU 13
10 x 05 (test system)
10 x 10 (test system)
10 x 05 (test system)
10 x 10 (test system)
10 x 05 (single slides)
10 x 10 (single slides)
FI 2822-1001-1 G
FI 2822-1002-1 G
FI 2822-1001-1 M *
FI 2822-1002-1 M *
Exanthema Profile 1
(consisting of 21 different substrates)
IgG

IgM

field A: verification BIOCHIP, HHV-6,
Rubella virus*, Measles virus,
Mumps virus
field B: VZV, EBV-CA, EBV-EA,
Treponema pallidum
field C: HSV-1 and -2, Coxsackie virus
type B1 and A9
field D: Echo virus type 7, Borrelia
afzelii, burgdorferi (CH), garinii
field E: CMV, Candida albicans,
krusei*, tropicalis*

10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
FI 2823-1001-1 G *
FI 2823-1002-1 G *
FI 2823-1001-1 M *
FI 2823-1002-1 M *
Lymphadenitis Profile 1
(consisting of 21 different substrates)
IgG

IgM

field A: verification BIOCHIP, HIV-1*
and 2*, HHV-6, Rubella virus*
field B: measles virus, Mumps virus,
Adenovirus type 3,
Parainfluenza virus type 1
field C: EBV-CA, EBV-EA, Toxoplasma
gondii, Treponema pallidum
field D: HSV-1 and -2, CMV,
Coxsackie virus type B5
field E: Coxsackie virus type A9,
Bartonella henselae, Chlamydia
trachomatis and pneumoniae

10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
FI 2824-1001-1 G
FI 2824-1002-1 G
FI 2824-1001-1 M *
FI 2824-1002-1 M *
Central Nervous System Profile 1
(consisting of 21 different substrates)
IgG

IgM

field A: verification BIOCHIP,
Rubella virus*, Measles virus,
Mumps virus, VZV
field B: Adenovirus type 3, EBV-CA,
Treponema pallidum,
Toxoplasma gondii
field C: HSV-1 and -2, Coxsackie virus
type B1 and A7
field D: Echo virus type 7, Borr. afzelii,
burgdorferi (CH), garinii
field E: CMV, Haemophilus influenzae*,
Listeria monocytogenes 1/2a und 4b

10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
FI 2825-1001-1 G
FI 2825-1002-1 G
FI 2825-1001-1 M
FI 2825-1002-1 M
Myocarditis Profile 1
(consisting of 17 different substrates)
IgG

IgM

field A: verification BIOCHIP, Mumps
virus, Adenovirus type 3, Influenza
virus type A (H1N1 and H3N2)
field B: Influenza virus Typ B,
Parainfluenza virus type 1 and 2,
Mycoplasma pneumoniae
field C: CMV, Coxsackie virus type B1
and A16, Echo virus type 7
field D: Borrelia afzelii, burgdorferi (CH),
garinii, Chlamydia pneumoniae

10 x 01 (test system)
10 x 02 (test system)
10 x 01 (test system)
10 x 02 (test system)
CK 2630-0220-L G
CSQ pair of controls
anti-Mumps virus (IgG)
IgG



2 x 2 ml, ready for use
CI 2630-0101 G
antibodies against Mumps virus
IgG positive control
IgG


0.1 ml
CI 2630-0101 Z
Mumps virus
negative control
IgG, IgM


0.1 ml
CI 2630-0101 M
antibodies against Mumps virus
IgM positive control
IgM


0.1 ml

*) Currently not available as IVD in the European Union.